Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2005 2
2006 1
2007 1
2008 3
2009 3
2010 3
2011 1
2012 5
2013 3
2014 4
2016 2
2017 9
2018 2
2019 15
2020 13
2021 11
2022 13
2023 17
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patients.
Wallmeier P, Arnold S, Tais A, Ihorst G, Janoschke M, Schubach F, Aries P, Bergner R, Bremer JP, Görl N, Gutdeutsch E, Hellmich B, Henes J, Hoyer BF, Kangowski A, Kötter I, Krusche M, Magnus T, Metzler C, Müller-Ladner U, Schaier M, Schönermarck U, Thiel J, Unger L, Venhoff N, Weinmann-Menke J, Petersen J, Lamprecht P, Iking-Konert C. Wallmeier P, et al. Among authors: venhoff n. Clin Exp Rheumatol. 2024 Apr;42(4):895-904. doi: 10.55563/clinexprheumatol/d3o0gu. Epub 2024 Apr 19. Clin Exp Rheumatol. 2024. PMID: 38683207 Free article.
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV patients.
Arnold S, Wallmeier P, Tais A, Ihorst G, Janoschke M, Schubach F, Aries P, Bergner R, Bremer JP, Görl N, Gutdeutsch E, Hellmich B, Henes J, Hoyer BF, Kangowski A, Kötter I, Krusche M, Magnus T, Metzler C, Müller-Ladner U, Petersen J, Reichelt de Tenorio A, Schaier M, Schirmer JH, Schönermarck U, Thiel J, Unger L, Venhoff N, Weinmann-Menke J, Iking-Konert C, Lamprecht P. Arnold S, et al. Among authors: venhoff n. Clin Exp Rheumatol. 2024 Apr;42(4):852-858. doi: 10.55563/clinexprheumatol/suxkyq. Epub 2024 Apr 12. Clin Exp Rheumatol. 2024. PMID: 38607682 Free article.
Association of rheumatological markers with neuronal antibodies, cerebrospinal fluid, electroencephalography, and magnetic resonance imaging findings in 224 patients with psychotic syndromes.
Endres D, von Zedtwitz K, Nickel K, Runge K, Maier A, Domschke K, Salzer U, Prüss H, Venhoff N, van Elst LT. Endres D, et al. Among authors: venhoff n. Brain Behav Immun. 2024 Apr 8;119:482-493. doi: 10.1016/j.bbi.2024.04.001. Online ahead of print. Brain Behav Immun. 2024. PMID: 38599500 Free article.
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Rech J, Tascilar K, Hagen M, Kleyer A, Manger B, Schoenau V, Hueber AJ, Kleinert S, Baraliakos X, Braun J, Kiltz U, Fleck M, Rubbert-Roth A, Kofler DM, Behrens F, Feuchtenberger M, Zaenker M, Voll R, Venhoff N, Thiel J, Glaser C, Feist E, Burmester GR, Karberg K, Strunk J, Cañete JD, Senolt L, Filkova M, Naredo E, Largo R, Krönke G, D'Agostino MA, Østergaard M, Schett G. Rech J, et al. Among authors: venhoff n. Lancet. 2024 Mar 2;403(10429):850-859. doi: 10.1016/S0140-6736(23)02650-8. Epub 2024 Feb 13. Lancet. 2024. PMID: 38364841 Clinical Trial.
Depression with anti-myelin antibodies in the cerebrospinal fluid.
Endres D, Berninger L, Glaser C, Hannibal L, Berger B, Nickel K, Runge K, Reisert M, Urbach H, Domschke K, Venhoff N, Prüss H, Tebartz van Elst L. Endres D, et al. Among authors: venhoff n. Mol Psychiatry. 2024 Feb 7. doi: 10.1038/s41380-024-02436-5. Online ahead of print. Mol Psychiatry. 2024. PMID: 38321121 No abstract available.
The IL-17 pathway as a target in giant cell arteritis.
Zeisbrich M, Thiel J, Venhoff N. Zeisbrich M, et al. Among authors: venhoff n. Front Immunol. 2024 Jan 17;14:1199059. doi: 10.3389/fimmu.2023.1199059. eCollection 2023. Front Immunol. 2024. PMID: 38299156 Free PMC article. Review.
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial.
Venhoff N, Schmidt WA, Bergner R, Rech J, Unger L, Tony HP, Finzel S, Andreica I, Kofler DM, Weiner SM, Lamprecht P, Schulze-Koops H, App C, Pournara E, Mendelson MH, Sieder C, Maricos M, Thiel J. Venhoff N, et al. Lancet Rheumatol. 2023 Jun;5(6):e341-e350. doi: 10.1016/S2665-9913(23)00101-7. Lancet Rheumatol. 2023. PMID: 38251601 Clinical Trial.
115 results